Stock Analysis·← Pickers

SIGA

SIGA Technologies, Inc.

SIGA Technologies, Inc. (SIGA) is currently in a downtrend, trading below both the 50-day and 200-day moving averages. RSI is at 35.9, with 0/3 trend checks passing.

Price
$3.56
2026-07-16
Trend score
0/3
Downtrend
RSI (14)
35.9
Neutral
Price above MA50Price above MA200MA50 above MA200
Change stock
Search another ticker to view its stock analysis page.
Chart View

SIGA with MA50 and MA200

9.487.966.454.943.4207/3110/2401/2204/1707/15
SIGA2025-07-312026-07-15
PriceMA50MA200
Technical Indicators

Key levels & signals

MA50
$4.23-15.90% vs price
MA200
$5.88-39.49% vs price
RSI (14)
35.9Neutral zone
MACD Signal
MixedMACD near signal line
Macro Support
Not identifiedNo repeated weekly support zone found
Support Quality
Volume data unavailable
Chart Summary
Trend summary for SIGA

SIGA Technologies, Inc. (SIGA) currently looks weaker on the chart and is not showing much trend strength. The latest available price is $3.56, and 0 of 3 core trend checks are currently passing. Price is trading below the 50-day moving average by 15.9% and below the 200-day moving average by 39.5%.

Momentum and stretch context

SIGA currently has an RSI reading of 35.9, which leans a little softer than neutral. That does not automatically make the chart bearish, but it does suggest momentum is not especially strong right now.

What traders may watch next

For traders reviewing SIGA next, the main question is whether weakness is starting to stabilise or whether the chart still looks vulnerable to further downside. Some traders may watch for bounce attempts, but others will want to see stronger proof that the trend is improving before treating the stock as a cleaner setup.

Company profile

About SIGA Technologies, Inc.

SIGA Technologies, Inc. is a pharmaceutical company with commercialized products, specializing in the health security and infectious disease sectors across the United States. A core offering is TPOXX, an oral antiviral drug formulated to combat human smallpox, a condition caused by the variola virus. Furthermore, the company has forged a strategic collaboration with Cipla Therapeutics. This partnership aims to ensure ongoing innovation and accessibility of antibacterial treatments, particularly those designed to counter biothreats. Founded in 1995, SIGA Technologies' corporate headquarters are located in New York, New York.

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Diem Nguyen
Employees
49
Market cap
$255.3M
Beta
0.89
52-week range
$3.41 – $9.62
Dividend
Yes · $1.20
Exchange
NASDAQ
Country
US
IPO date
10 Sept 1997
ISIN
US8269171067
CUSIP
826917106
Website
siga.com
Company profile data from Financial Modeling Prep. SIGA listed on NASDAQ.
Share dilution

SIGA shares outstanding over time

Tracking total shares outstanding is one way to spot dilution — a rising line means the company has issued more shares (stock-based compensation, secondary offerings, convertible debt), which spreads the same earnings and ownership across more shares. A falling line usually reflects buybacks.

Jun 2019Mar 2026
Shares outstanding (latest)
71.7M
Since Jun 2019
-11.5%
Trend
Fewer shares outstanding (buybacks)
Historical shares-outstanding data from Financial Modeling Prep. SIGA28 data points from Jun 2019 to Mar 2026.
Learn More

Learn the indicators behind this page

Explore More

More stock opportunities

FAQ

Common questions about SIGA

Is this page a buy or sell recommendation?

No. This page is designed to help you review chart structure, momentum and technical context more quickly, but it is not personal financial advice.

Why can a stock look bullish and overbought at the same time?

Strong trending stocks can still become stretched in the short term. That is why trend traders and dip buyers can read the same chart differently.

What should I do next after reading this page?

Open the full dashboard, review the chart in more detail, compare indicators, and decide whether the setup still makes sense within your own process.